WRAIR Vaccine Production Facility Research (Army)
Abstract
The WRAIR Vaccine Pilot Bioproduction Facility (PBF) is the Department of Defense’s only facility capable of producing good manufacturing practices (GMP) quality biologic products for use in early phase clinical trials. The mission of the WRAIR PBF is to support the development and licensure of vaccines and relevant biologics critical to the global health of our Warfighters serving domestically or abroad in compliance with US Food and Drug Administration (FDA) regulations. Funding supports a baseline level of preparedness for vaccine production and improved response-time in the setting of known and emerging infectious disease threats needing a preventive countermeasure while working with a collaborative network of partners. This project supports vaccine development efforts of strategic importance to the DoD, including Service medical research and development programs, those of other DoD organization such as the Defense Threat Reduction Agency and the Defense Advanced Research Projects Agency, and pandemic biopreparedness for emerging infectious disease threats in the Global Health Security Agenda.
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2022
- Source ID
- 504_0603115DHA_2_0130_PB_2022
Related Documents
- Root: Medical Technology Development
- Child Accomplishment: WRAIR Vaccine Production Facility